The role of N6-methyladenosine RNA modification in programmed and aberrant DNA mutagenesis in B cells
N6-甲基腺苷 RNA 修饰在 B 细胞程序性和异常 DNA 突变中的作用
基本信息
- 批准号:10598241
- 负责人:
- 金额:$ 3.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-09 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAllelesAntibodiesAntibody AffinityAntigensAutomobile DrivingB lymphoid malignancyB-Cell DevelopmentB-LymphocytesBiochemistryBiological AssayBiologyBone MarrowCell LineCell LineageCell physiologyChromosomal InstabilityChromosome abnormalityCodeComplexCorrelative StudyCoupledDNADNA Double Strand BreakDNA ProbesDNA Sequence AlterationDNA Single Strand BreakDNA StructureDataDefectDiseaseEnzymesEvaluationEventFrequenciesGene ActivationGene ExpressionGene RearrangementGenerationsGenesGenetic RecombinationGenetic TranscriptionGenomeGenome StabilityGenomic InstabilityGenomicsGoalsHeavy-Chain ImmunoglobulinsHematopoiesisHeterodimerizationIgG1Immune System DiseasesImmunizeImmunoglobulin AImmunoglobulin Class SwitchingImmunoglobulin GenesImmunoglobulin Somatic HypermutationImmunoglobulin Switch RecombinationImmunoglobulinsLaboratoriesLightLymphoidLymphomagenesisMature B-LymphocyteMediatingMethylationMicroscopyModificationMolecularMultiple MyelomaMusMutagenesisMutationPathway interactionsPeyer&aposs PatchesPlayPost-Transcriptional RegulationPreventionProcessProductionPropertyProteinsRNARNA DegradationRNA ProcessingRNA methylationResearch DesignResolutionRestRoleSingle-Stranded DNASiteSomatic MutationSterilityStructureStructure of germinal center of lymph nodeSystemTranscriptUntranslated RNAV(D)J Recombinationactivation-induced cytidine deaminaseadaptive immune responsecancer cellcellular developmentds-DNAepigenomicsexosomeexperimental studygenome integrityin vivolarge cell Diffuse non-Hodgkin&aposs lymphomaleukemia/lymphomamouse geneticsmouse modelmutantpreventprogenitorrecruitsingle moleculetranscriptome sequencing
项目摘要
PROJECT SUMMARY
Background: VDJ recombination, Class switch recombination (CSR) and somatic hypermutation (SHM) are
three B lymphocyte specific processes that mediate antibody gene diversification. VDJ recombination requires
the DNA double strand generation by the Recombination activation genes (RAG1 an RAG2) where as CSR and
SHM requires the single-strand DNA break activity of the Activation Induced Deaminase (AID) enzyme. Both
RAG1/2 and AID activities are coupled with noncoding RNA transcription at sites of DNA break/mutation. The
properties of the ncRNAs generated at sites of programmed DNA breaks are poorly characterized in B cells.
Recently advances in biology has provided compelling evidence that post-transcriptional and co-transcriptional
modification of ncRNAs determine a component of RNA epigenomics and have significant role in driving
cellular development and function. In this application, supported by preliminary data generated in our
laboratory, we are evaluating the role of RNA modification N6-methyladenosine (m6A) and its associated
enzymes METTL3 and METTL14 in B cell development, function and genomic integrity.
Objective/Hypothesis: In his proposal, we will determine how RNA methylation m6A on transcripts
generated in the IgH locus and the rest of the B cell genome controls programmed DNA recombination,
antibody gene diversification and prevents chromosomal instability.
Specific Aims: Aim 1: Aim 1: Are m6A modifying enzymes Mettl3 and Mettl14 important for class switch
recombination, somatic hypermutation, and/or for preventing genomic stability in B cells? ; AIM 2: What is the
mechanism by which m6A modification promotes IgH DNA recombination and/or prevents genomic
instability? AIM 3: Do RNA methylation and coupled RNA surveillance pathways have a role in early B cell
development and during VDJ recombination?
Study Design: Using cell lines and mouse models, we will study mechanism by which RNA m6A methylation
plays a role in programmed DNA recombination and protection of B cell genomic integrity. We will evaluate
the mechanism of formation of single-strand DNA structures formation and RNA surveillance at sites of AID
activity in matured B cells and the mechanism by which inhibitory RNAs are degraded at sites of RAG activity
in B cells during VDJ recombination. We will also evaluate the molecular mechanism by which RNA
modification promotes programmed DNA rearrangements. We use a combination of mouse genetics, genomics,
biochemistry and 3D-STORM microscopy to accomplish the goals of the proposed project.
Disease Relevance: B cells are a central component of the adaptive immune response, but also prone to
undergo leukemias and lymphomas when antibody gene diversification processes are not well controlled.
Proposed studies leads to a better understanding of the mechanism of antibody gene diversification but also
educate us how B cell cancer (specially in context of DLBCL and Multiple Myeloma) are prevented.
项目概要
背景:VDJ重组、类别转换重组(CSR)和体细胞超突变(SHM)是
介导抗体基因多样化的三个 B 淋巴细胞特异性过程。 VDJ重组需要
由重组激活基因(RAG1 和 RAG2)产生 DNA 双链,其中 CSR 和
SHM 需要激活诱导脱氨酶 (AID) 的单链 DNA 断裂活性。两个都
RAG1/2 和 AID 活性与 DNA 断裂/突变位点的非编码 RNA 转录相结合。这
在 B 细胞中,在程序性 DNA 断裂位点生成的 ncRNA 的特性尚不清楚。
最近生物学的进展提供了令人信服的证据,证明转录后和共转录
ncRNA 的修饰决定了 RNA 表观基因组学的一个组成部分,并在驱动
细胞的发育和功能。在此应用程序中,由我们生成的初步数据支持
实验室,我们正在评估 RNA 修饰 N6-甲基腺苷 (m6A) 及其相关的作用
METTL3 和 METTL14 酶在 B 细胞发育、功能和基因组完整性中的作用。
目标/假设:在他的提议中,我们将确定转录本上的 RNA 甲基化 m6A
在 IgH 基因座中产生,B 细胞基因组的其余部分控制着程序性 DNA 重组,
抗体基因多样化并防止染色体不稳定。
具体目标: 目标 1: 目标 1: m6A 修饰酶 Mettl3 和 Mettl14 对于类别转换是否重要
重组、体细胞超突变和/或防止 B 细胞基因组稳定性? ;目标 2:什么是
m6A 修饰促进 IgH DNA 重组和/或阻止基因组重组的机制
不稳定?目标 3:RNA 甲基化和偶联 RNA 监视途径在早期 B 细胞中起作用吗
发展和VDJ重组期间?
研究设计:使用细胞系和小鼠模型,我们将研究 RNA m6A 甲基化的机制
在程序性 DNA 重组和保护 B 细胞基因组完整性中发挥作用。我们将评估
AID位点单链DNA结构形成和RNA监测的形成机制
成熟 B 细胞中的活性以及抑制性 RNA 在 RAG 活性位点被降解的机制
VDJ 重组期间 B 细胞中。我们还将评估 RNA 的分子机制
修饰促进程序性 DNA 重排。我们结合小鼠遗传学、基因组学、
生物化学和 3D-STORM 显微镜来实现拟议项目的目标。
疾病相关性:B 细胞是适应性免疫反应的核心组成部分,但也容易发生
当抗体基因多样化过程没有得到很好的控制时,就会患上白血病和淋巴瘤。
拟议的研究可以更好地理解抗体基因多样化的机制,但也
告诉我们如何预防 B 细胞癌(特别是 DLBCL 和多发性骨髓瘤)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Uttiya Basu其他文献
Uttiya Basu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Uttiya Basu', 18)}}的其他基金
FASEB's "The RNA Associated Mechanisms Conference: In Immunity and Disease"
FASEB 的“RNA 相关机制会议:免疫与疾病”
- 批准号:
9993686 - 财政年份:2021
- 资助金额:
$ 3.51万 - 项目类别:
The role of N6-methyladenosine RNA modification in programmed and aberrant DNA mutagenesis in B cells
N6-甲基腺苷 RNA 修饰在 B 细胞程序性和异常 DNA 突变中的作用
- 批准号:
10461710 - 财政年份:2020
- 资助金额:
$ 3.51万 - 项目类别:
The role of N6-methyladenosine RNA modification in programmed and aberrant DNA mutagenesis in B cells
N6-甲基腺苷 RNA 修饰在 B 细胞程序性和异常 DNA 突变中的作用
- 批准号:
9897023 - 财政年份:2020
- 资助金额:
$ 3.51万 - 项目类别:
The role of N6-methyladenosine RNA modification in programmed and aberrant DNA mutagenesis in B cells
N6-甲基腺苷 RNA 修饰在 B 细胞程序性和异常 DNA 突变中的作用
- 批准号:
10721410 - 财政年份:2020
- 资助金额:
$ 3.51万 - 项目类别:
The role of N6-methyladenosine RNA modification in programmed and aberrant DNA mutagenesis in B cells
N6-甲基腺苷 RNA 修饰在 B 细胞程序性和异常 DNA 突变中的作用
- 批准号:
10259665 - 财政年份:2020
- 资助金额:
$ 3.51万 - 项目类别:
The role of N6-methyladenosine RNA modification in programmed and aberrant DNA mutagenesis in B cells
N6-甲基腺苷 RNA 修饰在 B 细胞程序性和异常 DNA 突变中的作用
- 批准号:
10682918 - 财政年份:2020
- 资助金额:
$ 3.51万 - 项目类别:
The role of N6-methyladenosine RNA modification in programmed and aberrant DNA mutagenesis in B cells
N6-甲基腺苷 RNA 修饰在 B 细胞程序性和异常 DNA 突变中的作用
- 批准号:
10683111 - 财政年份:2020
- 资助金额:
$ 3.51万 - 项目类别:
Long noncoding RNA expressing genomic element that control antibody diversification and chromosomal integrity in B cells
表达控制 B 细胞抗体多样化和染色体完整性的基因组元件的长非编码 RNA
- 批准号:
10303057 - 财政年份:2017
- 资助金额:
$ 3.51万 - 项目类别:
Long noncoding RNA expressing genomic elements that control antibody diversification and chromosomal integrity in B cells
表达控制 B 细胞抗体多样化和染色体完整性的基因组元件的长非编码 RNA
- 批准号:
10531294 - 财政年份:2017
- 资助金额:
$ 3.51万 - 项目类别:
Long noncoding RNA expressing genomic element that control antibody diversification and chromosomal integrity in B cells
表达控制 B 细胞抗体多样化和染色体完整性的基因组元件的长非编码 RNA
- 批准号:
10065485 - 财政年份:2017
- 资助金额:
$ 3.51万 - 项目类别:
相似国自然基金
等位基因聚合网络模型的构建及其在叶片茸毛发育中的应用
- 批准号:32370714
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于人诱导多能干细胞技术研究突变等位基因特异性敲除治疗1型和2型长QT综合征
- 批准号:82300353
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肠杆菌多粘菌素异质性耐药中phoPQ等位基因差异介导不同亚群共存的机制研究
- 批准号:82302575
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ACR11A不同等位基因调控番茄低温胁迫的机理解析
- 批准号:32302535
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
玉米穗行数QTL克隆及优异等位基因型鉴定
- 批准号:
- 批准年份:2022
- 资助金额:55 万元
- 项目类别:面上项目
相似海外基金
Develop an engineered Cas effector for in vivo cell-targeted delivery in the eye to treat autosomal dominant BEST disease
开发工程化 Cas 效应器,用于眼内体内细胞靶向递送,以治疗常染色体显性 BEST 疾病
- 批准号:
10668167 - 财政年份:2023
- 资助金额:
$ 3.51万 - 项目类别:
Mapping heritable chromatin loop variants with allele-specific Hi-C analysis
通过等位基因特异性 Hi-C 分析绘制可遗传的染色质环变体图谱
- 批准号:
10583721 - 财政年份:2023
- 资助金额:
$ 3.51万 - 项目类别:
Mechanisms of autoimmune disease risk in IL2/IL2RA-dependent immune tolerance
IL2/IL2RA依赖性免疫耐受中自身免疫性疾病风险的机制
- 批准号:
10358624 - 财政年份:2021
- 资助金额:
$ 3.51万 - 项目类别:
Mechanisms of autoimmune disease risk in IL2/IL2RA-dependent immune tolerance
IL2/IL2RA依赖性免疫耐受中自身免疫性疾病风险的机制
- 批准号:
10553203 - 财政年份:2021
- 资助金额:
$ 3.51万 - 项目类别:
Regeneration and remodeling of collecting lymphatic vessels post-injury
损伤后集合淋巴管的再生和重塑
- 批准号:
10534652 - 财政年份:2021
- 资助金额:
$ 3.51万 - 项目类别: